FDA, COVID and vaccine
Digest more
Top News
Overview
Impacts
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
Wellbeing Whisper on MSN2d
FDA's New Covid-19 Vaccine Strategy Could Leave Millions of Healthy Adults Without Access to BoostersWe have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters,” Dr. Vinay Prasad, FDA’s new highest-ranking vaccines official, recently stated in a video published by the agency.
Robert F. Kennedy Jr. secures a prominent health role, pledging reform in vaccine approval. The FDA plans significant changes under Dr. Vinay Prasad's leadership, sparking debates on the future of vaccinations.
This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing that there is not much evidence to support the value of annual shots in healthy people.
Wellbeing Whisper on MSN2d
Navigating the New COVID-19 Vaccine Rules Who Can Get the Updated Shots This FallThe truth is that for most of that, for many Americans, we simply do not know the answer to whether or not they should be getting the seven or eight or nine or ten, as the current policy would have us,
On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study. The news came a week after Election Day in 2020 and shortly after former President Joe Biden was projected to win on Nov. 7.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.
Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate vaccines and public health systems brace for another season of jabs and logistics.